Posts

Welcome to the Fritsma Factor, please join our hemostasis discussions.

From Alan Neal, Pathlab, NZ. Just wanted a private conversation about the January 11, 2018 Fritsma...
Jan 22, 2018 10:41am
We've recently updated our Conferences Calendar. If you would like your conference to be listed,...
Jan 20, 2018 2:03pm
The International Society on Thrombosis and Haemostasis annual SSC meeting is July 18–21, 2018, in...
Jan 17, 2018 1:13pm
From Jasmina Ahluwalia, MD: Hello George, We use the IL vWF Antigen (VWF:Ag) and vWF Ristocetin...
Jan 11, 2018 8:29pm
Jan 22, 2018 10:41am
From Alan Neal, Pathlab, NZ. Just wanted a private conversation about the January 11, 2018 Fritsma Factor entry, "POC and Plasma-Based PT/INRs." I do not agree with the comments made within this article and challenge the logic used. Essentially, if monitoring an enzymatic pathway such as coagulation, with the 'detector' being used is fibrinogen to fibrin, then that rate of reaction will be dependent on the substrate concentration, i. e., fibrinogen, and the sensitivity of the analyser to detect the end point. So if no or reduced fibrinogen or dysfibrinogen, then reduced Vmax and hence PT/INR will be more prolonged than test system using a clot based end point detection.
0 Comments
Jan 20, 2018 2:03pm
We've recently updated our Conferences Calendar. If you would like your conference to be listed, please contact George at george@fritsmafactor.com.
0 Comments
Jan 17, 2018 1:13pm
The International Society on Thrombosis and Haemostasis annual SSC meeting is July 18–21, 2018, in Dublin. Delegates who would like to present their work at
0 Comments
Jan 11, 2018 8:29pm
From Jasmina Ahluwalia, MD: Hello George, We use the IL vWF Antigen (VWF :Ag) and vWF Ristocetin Cofactor (VWF :RCo) activity kits on the ACL TOP 500 analyser.
0 Comments